
Deep learning-based precise non-invasive coronary functional assessment
Keya Medical is a high-tech enterprise that focuses on artificial intelligence (AI)-powered medical imaging diagnostics. Its core product, DeepVessel FFR, uses deep learning algorithms to calculate the fractional flow reserve from coronary CT angiography, enabling non-invasive and precise coronary functional assessment and providing clinicians with decision support for the diagnosis of coronary heart disease.
Keya Medical's technology integrates medical image processing, fluid dynamics simulation, and deep learning models, enabling fully automated analysis to be completed within minutes, significantly improving diagnostic efficiency and accuracy. The product has successfully obtained the NMPA Class III medical device registration certificate and has been widely deployed in hundreds of hospitals across the country.
In addition to coronary AI, Keya Medical has also launched product lines such as pulmonary nodule AI and stroke AI, covering multi-site disease screening. The company is committed to empowering hierarchical diagnosis and treatment through AI technology, with the ultimate goal of reducing medical costs.
Cardiologists, Radiologists, Interventional physicians, Chest pain centers, Health check-up centers, Tertiary hospitals, Primary care institutions
Averroes AIFreeAI visual inspection software for manufacturing — catch every defect with 99%+ accuracy, live in days.
Voxel51FreeA data-centric platform for building, evaluating, and optimizing physical AI systems with computer vision at scale.
PearlFreeFDA-cleared dental AI software that helps dentists and DSOs deliver smarter, faster, and more productive patient care.
LEAFIO AIFreeAI-driven retail inventory optimization platform that aligns demand forecasting, replenishment, and assortment planning for maximum profitability.
V7 GoFreeV7 Go is an operational AI platform purpose-built for private equity, finance, insurance, and real estate teams, automating CIM analysis, DDQ completion, IC memo generation, and portfolio monitoring throughout the investment lifecycle.